Upgrade to SI Premium - Free Trial

Ultragenyx Pharma (RARE)

27.02 -0.62 (2.24%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Tactical Resources Announces Exchange Ratio for Business Combination with Plum Acquisition Corp. III July 22, 2026 8:30 AM - BizWire Ultragenyx Pharma (RARE) PT Raised to $77 at Jefferies July 20, 2026 5:37 PM - StreetInsider Tactical Resources and Plum Acquisition Corp. III Announce Receipt of Nasdaq Approval; Transaction Expected to Close on July 28, 2026 July 20, 2026 8:30 AM - BizWire Ultragenyx releases 2025 impact report on rare disease programs July 8, 2026 9:08 AM - StreetInsider Ultragenyx Releases 2025 Impact Report Emphasizing Commitment to Rare Disease Patients, Innovation, and Global Impact July 8, 2026 9:08 AM - Globe NewsWire Ultragenyx Pharma (RARE) PT Raised to $40 at RBC Capital July 7, 2026 7:59 AM - StreetInsider Form 4 Ultragenyx Pharmaceutica For: Jul 01 Filed by: Horn Howard July 6, 2026 3:37 PM - SEC Filing Form 144 Ultragenyx Pharmaceutica Filed by: Horn Howard July 1, 2026 4:19 PM - SEC Filing Calidi Biotherapeutics adds biopharma veteran Corsee Sanders to board June 23, 2026 8:00 AM - StreetInsider Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors June 23, 2026 8:00 AM - StreetInsider Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) June 19, 2026 4:30 PM - StreetInsider Form 4 Ultragenyx Pharmaceutica For: Jun 15 Filed by: Sanders Corazon (Corsee) D. June 15, 2026 6:51 PM - SEC Filing Form 4 Ultragenyx Pharmaceutica For: Jun 15 Filed by: Parschauer Karah Herdman June 15, 2026 6:46 PM - SEC Filing Form 144 Ultragenyx Pharmaceutica Filed by: Parschauer Karah Herdman June 15, 2026 4:51 PM - SEC Filing Form 144 Ultragenyx Pharmaceutica Filed by: Sanders Corazon (Corsee) D. June 15, 2026 4:12 PM - SEC Filing Form S-8 Ultragenyx Pharmaceutica June 12, 2026 1:40 PM - SEC Filing Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference June 3, 2026 4:30 PM - StreetInsider Form 4 Ultragenyx Pharmaceutica For: Jun 01 Filed by: Horn Howard June 1, 2026 7:12 PM - SEC Filing Form 144 Ultragenyx Pharmaceutica Filed by: Horn Howard June 1, 2026 4:09 PM - SEC Filing Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 22, 2026 4:30 PM - StreetInsider Ultragenyx Pharma (RARE) PT Raised to $96 at Cantor Fitzgerald May 21, 2026 6:36 AM - StreetInsider Ultragenyx Pharma (RARE) PT Lowered to $72 at JPMorgan May 20, 2026 7:37 AM - StreetInsider Form 4 Ultragenyx Pharmaceutica For: May 14 Filed by: Fust Matthew K May 18, 2026 6:51 PM - SEC Filing Form 4 Ultragenyx Pharmaceutica For: May 14 Filed by: SULIMAN SHEHNAAZ May 18, 2026 6:41 PM - SEC Filing Form 4 Ultragenyx Pharmaceutica For: May 14 Filed by: Ray Amrit May 18, 2026 6:40 PM - SEC Filing Form 4 Ultragenyx Pharmaceutica For: May 14 Filed by: Sanders Corazon (Corsee) D. May 18, 2026 6:39 PM - SEC Filing Form 4 Ultragenyx Pharmaceutica For: May 14 Filed by: NARACHI MICHAEL May 18, 2026 6:36 PM - SEC Filing Form 4 Ultragenyx Pharmaceutica For: May 14 Filed by: WELCH DANIEL G May 18, 2026 6:23 PM - SEC Filing Form 4 Ultragenyx Pharmaceutica For: May 14 Filed by: Dunsire Deborah May 18, 2026 6:21 PM - SEC Filing Form 144 Ultragenyx Pharmaceutica Filed by: SULIMAN SHEHNAAZ May 18, 2026 4:50 PM - SEC Filing Form 8-K Ultragenyx Pharmaceutica For: May 14 May 18, 2026 2:15 PM - SEC Filing Form SCHEDULE 13G Ultragenyx Pharmaceutica Filed by: STATE STREET CORP May 12, 2026 12:13 PM - SEC Filing Ultragenyx Pharma (RARE) PT Lowered to $43 at Guggenheim May 8, 2026 7:22 AM - StreetInsider Ultragenyx to Participate at Bank of America’s 2026 Healthcare Conference May 6, 2026 4:30 PM - StreetInsider Form 4 Ultragenyx Pharmaceutica For: May 05 Filed by: Crombez Eric May 6, 2026 2:51 PM - SEC Filing Ultragenyx Pharma (RARE) PT Raised to $47 at Wells Fargo May 6, 2026 8:49 AM - StreetInsider Form 10-Q Ultragenyx Pharmaceutica For: Mar 31 May 6, 2026 6:03 AM - SEC Filing Ultragenyx Pharma (RARE) Misses Q1 EPS by 38c, provides guidance May 5, 2026 4:34 PM - StreetInsider Form 8-K Ultragenyx Pharmaceutica For: May 05 May 5, 2026 4:07 PM - SEC Filing Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update May 5, 2026 4:01 PM - Globe NewsWire Form 4 Ultragenyx Pharmaceutica For: May 01 Filed by: Horn Howard May 4, 2026 5:36 PM - SEC Filing Form 144 Ultragenyx Pharmaceutica Filed by: Horn Howard May 1, 2026 4:07 PM - SEC Filing Form DEFA14A Ultragenyx Pharmaceutica April 30, 2026 4:06 PM - SEC Filing Form SCHEDULE 13G Ultragenyx Pharmaceutica Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC April 29, 2026 3:48 PM - SEC Filing Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate Update April 29, 2026 8:00 AM - Globe NewsWire Ultragenyx Pharma (RARE) PT Lowered to $43 at Barclays April 29, 2026 2:18 AM - StreetInsider Form 4 Ultragenyx Pharmaceutica For: Apr 22 Filed by: Huizenga Theodore Alan April 24, 2026 4:40 PM - SEC Filing Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) April 24, 2026 4:30 PM - StreetInsider Full Article List